Close
Queen Square Multiple Sclerosis Centre
UPDATES:
NEW REFUEL-MS trial, working on a treatment to help manage
MS-fatigue: https://www.refuel-ms.com/
OCTOPUS IN THE NEWS!
- 'Major moment in MS research' as new Octopus trial starts – BBC Website
- Octopus ‘mega trial’ opens to progressive MS patients in the UK – Multiple Sclerosis News Today
- World first trial for progressive MS patients launches in UK – UCL News.
REGISTER FOR OCTOPUS – a revolutionary trial that will transform the way we test treatments for progressive MS.
ALEXANDER DISEASE (AxD): New MS clinical trial.
MS-STAT2 TRIAL UPDATE: April 2023.
AttackMS: New MS clinical trial.
ChariotMS: New MS clinical trial.
MS Laboratory Research
A wide range of techniques and expertise is applied to understanding the mechanisms responsible for MS, and developing new therapeutic strategies.
MS Clinical Research
The Queen Square Multiple Sclerosis Centre unites research expertise and care in MS that exists at the UCL Queen Square Institute of Neurology and the UCLH National Hospital for Neurology and Neurosurgery, Queen Square, in Central London. In addition the Centre links the wide variety of MS research across the different sites of UCL.
MS Clinical Trials
Clinical Trials on new therapies for MS are based at the National Hospital for Neurology and Neurosurgery (NHNN) and the Leonard Wolfson Experimental Neurology Centre (LWENC) based in Queen Square.
MS Clinical Services
At the National Hospital for Neurology and Neurosurgery (NHNN) based in Queen Square a multidisciplinary team offers a wide range of expert specialist advice on all aspects of multiple sclerosis (MS), and carry out clinical research projects.
